Luna Genetics, Inc developed a novel approach, single cell prenatal diagnosis (SCPD), which uniquely captures fetal trophoblast cells in maternal blood early in pregnancy and uses advanced DNA analysis to detect a range of genetic abnormalities, including Down syndrome, trisomy 13, trisomy 18 and many smaller chromosomal abnormalities.